Fundraising

Investment Opportunity

Join us in revolutionizing early detection of neurodegenerative diseases. Partner with eNLife Research to transform millions of lives worldwide.

Market Opportunity

>$50B

Global Alzheimer’s diagnostics market by 2030

Target Population

440M+

People at risk globally need early detection

Grants Raised

15+

To decipher onset of Alzheimer’s Disease

Current

Pre-Seed

Target: Q4 2025
Government Grants, Angel Investors

Planned

Seed-Early Stage

Target: Q3 2027
VC

Committed

Target: Q4 2025
FSID

Key Milestones

Q2 2024

Q4 2024

Q2 2025

Use of Funds

R&D and Product Development ($1.125M)
45%
Clinical Trials ($625K)
25%
Regulatory Affairs ($375K)
15%
Team Expansion ($250K)
10%
Operations & Infrastructure ($125K)
$250K 5%

$100k

Minimum Investment

Preferred

Grants and Angels

1X

Liquidation Preference

10%

Employee Pool